Ceftriaxone exerts antitumor effects in MYCN‐driven retinoblastoma and neuroblastoma by targeting DDX3X for translation repression

MYCN proto‐oncogene, bHLH transcription factor (MYCN) amplification is associated with aggressive retinoblastoma (RB) and neuroblastoma (NB) cancer recurrence that is resistant to chemotherapies. Therefore, there is an urgent need to identify new therapeutic tools. This study aimed to evaluate the p...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Pamorn Chittavanich, Duangporn Saengwimol, Sittiruk Roytrakul, Duangnate Rojanaporn, Vijender Chaitankar, Atthapol Srimongkol, Usanarat Anurathapan, Suradej Hongeng, Rossukon Kaewkhaw
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-04-01
Colecção:	Molecular Oncology
Assuntos:	ceftriaxone DDX3X MYCN amplification neuroblastoma retinoblastoma translation
Acesso em linha:	https://doi.org/10.1002/1878-0261.13553
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!